News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Apnimed
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Money on the Move: April Showers Bring May Flowers—and Funding
Dianthus Therapeutics, Enavate Sciences and CytoTronics were all launched with this recent wave of investor funding. For that and more, continue reading.
May 4, 2022
·
4 min read
·
Hannah Chudleigh
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 16, 2026
·
12 min read
Press Releases
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - November 5, 2026
November 6, 2026
·
2 min read
Press Releases
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
October 12, 2026
·
7 min read
Press Releases
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - October 2, 2026
October 5, 2026
·
3 min read
Press Releases
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
September 8, 2026
·
13 min read
Press Releases
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - September 4, 2026
September 6, 2026
·
3 min read
Press Releases
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 3, 2026
·
3 min read
Press Releases
Apnimed Announces Pricing of Upsized Initial Public Offering
July 31, 2026
·
4 min read
Press Releases
Apnimed Announces FDA Acceptance of New Drug Application for AD109, An Investigational Oral Pill to Treat Adults with Obstructive Sleep Apnea (OSA)
July 14, 2026
·
4 min read
Press Releases
Apnimed Announces Upcoming Oral Presentation at SLEEP 2026 to Highlight Pooled Phase 3 Data for AD109 in Obstructive Sleep Apnea
June 10, 2026
·
6 min read